Improved Outcomes in Lower Eyelid Reconstruction With Biodegradable Implant: A Comparative Study

Area of Science:

• Ophthalmology
• Surgical Oncology
• Biomaterials Science

Background:

• Eyelid reconstruction is crucial after malignancy surgery to restore function and aesthetics.
• Traditional methods using grafts have limitations, including donor site availability and complications.
• Developing advanced reconstructive techniques is vital for improving patient outcomes.

Purpose of the Study:

• To evaluate the efficacy of a biodegradable implant in lower eyelid reconstruction.
• To compare outcomes between patients receiving the implant and those undergoing standard reconstruction.
• To assess the impact of the implant on healing, blood flow, and complication rates.

Main Methods:

• A prospective study involving 61 patients (58-91 years) undergoing lower eyelid reconstruction.
• Patients were divided into two groups: a treatment group (n=31) with a biodegradable implant and a control group (n=30) without.
• Follow-up was conducted for one year, with assessments including cytological analysis and laser Doppler flowmetry.

Main Results:

• The biodegradable implant group showed faster healing times and improved blood flow to the reconstructed eyelid.
• A reduced incidence of complications, such as ectropion, was observed in the treatment group.
• No significant differences were found in tear osmolarity or pH between the groups.

Conclusions:

• Biodegradable implants are a safe and effective option for lower eyelid reconstruction post-malignancy surgery.
• The use of these implants can accelerate healing, enhance vascularity, and minimize complications.
• This approach offers a promising alternative to traditional grafting techniques.